• We are investigating the genetics of pulmonary fibrosis
  • We are discovering ways to intervene at the earliest stage of disease, before scarring becomes irreversible

IPF Research hopes to be able to use genetics and biomarkers to make earlier diagnosies, find drug therapies, and offer earlier treatments.

Get More Information

Study staff will contact you within a week.

David Schwartz leading researcher of Pulmonary Fibrosis

David A. Schwartz, MD

Dr. Schwartz is Professor of Medicine and Immunology, and Chair of the Department of Medicine at University of Colorado.

University of Colorado School of Medicine
National Jewish Partner
Vanderbilt Partnership